CHICAGO EQUITY PARTNERS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 195 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$2,649,000
-52.3%
262,577
-37.1%
0.27%
-16.3%
Q4 2019$5,556,000
+68.5%
417,407
+8.7%
0.32%
+103.2%
Q3 2019$3,298,000
-21.8%
384,155
-0.4%
0.16%
-16.5%
Q2 2019$4,218,000
-19.7%
385,600
-0.7%
0.19%
-7.4%
Q1 2019$5,256,000
+79.9%
388,435
+37.8%
0.20%
+72.0%
Q4 2018$2,921,000
-45.7%
281,910
-3.2%
0.12%
-25.3%
Q3 2018$5,375,000
+15.1%
291,165
+19.2%
0.16%
+10.5%
Q2 2018$4,671,000
+37.1%
244,275
+10.7%
0.14%
+31.2%
Q1 2018$3,406,000
+6.3%
220,750
+3.3%
0.11%
+11.2%
Q4 2017$3,203,000
+71.9%
213,680
+80.9%
0.10%
+66.1%
Q3 2017$1,863,000
-34.6%
118,135
-21.7%
0.06%
-23.4%
Q2 2017$2,848,000
+36.1%
150,830
+23.0%
0.08%
+28.3%
Q1 2017$2,092,000
-0.2%
122,640
-10.5%
0.06%
+7.1%
Q4 2016$2,096,000
+52.9%
137,100
+58.8%
0.06%
+47.4%
Q3 2016$1,371,00086,3100.04%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders